Posted by Michael Wonder on 21 Jan 2024
Advanced melanoma treatment to be added to Pharmaceutical Benefits Scheme
21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the coming weeks.
Health Minister Mark Butler announced today that patients aged over 12 and living with recurrent or metastatic melanoma will be reimbursed for Opdualag (nivolumab, relatlimab).
